Coenzyme Q- Responsive Leigh's encephalopathy in two sisters

Annals of Neurology

Volumn 52, Issue 6, 2002, Pages 750-754

  Maldergem, Lionel Van ^a   Trijbels, Frans ^b   DiMauro, Salvatore ^c   Sindelar, Pavel J ^d   Musumeci, Olimpia ^c   Janssen, Antoon ^b   Delberghe, Xavier ^e   Martin, Jean Jacques ^f   Gillerot, Yves ^a  

^a Centre de Genetique Humaine   (Belgium)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c H Houston Merritt Clin Res Ctr ^*  (United States)

^d STOCKHOLM UNIVERSITY   (Sweden)

^e Inst Medico Pedagogique Montfort   (Belgium)

^f UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

SUCCINATE DEHYDROGENASE; UBIQUINONE;

ADULT; ARTICLE; ATAXIA; CASE REPORT; CAUDATE NUCLEUS; CEREBROSPINAL FLUID; CLINICAL FEATURE; ENZYME DEFICIENCY; FEMALE; FIBROBLAST; GROWTH RETARDATION; HEARING IMPAIRMENT; HUMAN; LACTIC ACIDOSIS; LEIGH DISEASE; LYMPHOBLAST; MUSCLE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PUTAMEN; TISSUE DISTRIBUTION;

ADULT; FEMALE; HUMANS; LEIGH DISEASE; MAGNETIC RESONANCE IMAGING; SIBLINGS; UBIQUINONE;

EID: 0036895391     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.10371     Document Type: Article

References (28)

1. Leigh D. Subacute necrotizing encephalomyelopathy in an infant. J Neurol Neurosurg Psychiatr 1951;14:216-221.
2. Dahl H-H. Getting to the nucleus of mitochondrial disorders: Identification of respiratory-chain enzyme genes causing Leigh syndrome. Am J Hum Genet 1998;63:1594-1597.
3. DiMauro S, DeVivo DC. Genetic heterogeneity in Leigh syndrome (letter). Ann Neurol 1996;40:5-7.
4. Ogasahara S, Engel AG, Frens D, Mack D. Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy. Proc Natl Acad Sci USA 1989;86:2379-2382.
5. Sobreira C, Hirano M, Shanske S, et al. Mitochondrial encephalomyopathy with coenzyme Q 10 deficiency. Neurology 1997;48:1238-1243.
6. Rötig A, Appelqvist EL, Geromel V, et al. Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency. Lancet 2000;356:391-395.
7. Musumeci O, Naini A, Slonim AE, et al. Familial cerebellar ataxia with muscle coenzyme Q10 deficiency. Neurology 2001;56:849-855.
8. Boitier E, Degoul F, Desguerre I, et al. A case of mitochondrial encephalomyopathy associated with a muscle coenzyme Q 10 deficiency. J Neurol Sci 1998;156:41-46.
9. Fischer JC, Ruitenbeek W, Berden JA, et al. Differential investigation of the capacity of succinate oxidation in human skeletal muscle. Clin Chim Acta 1985;153:23-36.
10. Fischer JC, Ruitenbeek W, Trijbels JMF, et al. Estimation of NADH oxidation in human skeletal muscle mitochondria. Clin Chim Acta 1986;155:263-273.
11. Lang JK, Gohil K, Packer L. Simultaneous determination of tocopherols, ubiquinols, and ubiquinones in blood, plasma, rissue homogenares, and subcellular fractions. Anal Biochem 1986;157:106-116.
12. Podda M, Weber C, Traber MG, et al. Sensitive high-performance liquid chromatography techniques for simultaneous determination of tocopherols, rocotrienols, ubiquinols, and ubiquinones in biological samples. Methods Enzymol 1999;299:330-341.
13. Zhu Z, Yao J, Johns T, et al. Surf-1, encoding a factor involved in the biogenesis of cytochrome c oxidase, is mutated in Leigh syndrome. Nat Genet 1998;20:337-343.
14. Valnot I, Osmond S, Gigarel N, et al. Mutations of the SCO1 gene in mitochondrial cytochrome c oxidase deficiency with neonatal-onset hepatic failure and encephalopathy. Am J Hum Genet 2000;67:1104-1109.
15. Valnot I, von Kleist-Retzow JC, Barrientos A, et al. A mutation in the human heme A: Farnesyltransferase gene (COX 10) causes cytochrome c oxidase deficiency. Hum Mol Genet 2000;9:1245-1249.
16. Papadopoulou LC, Sue CM, Davidson MM, et al. Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in SCO2, a COX assembly gene. Nat Genet 1999;23:333-337.
17. Ogasahara S, Nishikawa Y, Yorifuji S, et al. Treatment of KearnsSayre syndrome with coenzyme Q10. Neurology 1986;36:45-53.
18. Ihara Y, Namba R, Kuroda S, et al. Mitochondrial encephalomyopathy (MELAS): Pathological study and successful therapy with coenzyme Q and idebenone. J Neurol Sci 1989;90:263-271.
19. Nishikawa Y, Takahashi M, Yorifuji S, et al. Long-term coenzyme Q10 therapy for a mitochondrial encephalomyopathy with cytochrome c oxidase deficiency: A 31P NMR study. Neurology 1989;39:399-403.
20. Abe K, Fujimura H, Nishikawa Y, et al. Marked reduction in CSF lactate and pyruvate levels after CoQ therapy in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS). Acta Neurol Scand 1991;83:356-359.
21. Papadimitriou A, Hadjigeorgiou GM, Divari R, et al. The influence of coenzyme Q10 on total serum calcium concentration in two patients with Kearns-Sayre syndrome and hypoparathyroidism. Neuromuscul Disord 1996;6:49-53.
22. Hart ZH, Chang CH, Perrin EVD, et al. Familial poliodystrophy, mitochondrial myopathy, and lactate acidemia. Arch Neurol 1977;34:180-185.
23. Yorifuji S, Ogasawara S, Takahashi M, Tarui S. Decreased activities in mitochondrial inner membrane electron transport system in muscle from patients with Kearns-Sayre syndrome. J Neurol Sci 1985;71:65-75.
24. Goda S, Hamada T, Ishimoto S, et al. Clinical improvement after administration of coenzyme Q10 in a patient with mitochondrial encephalomyopathy. J Neurol 1987;234:62-63.
25. Matsuoka T, Maeda H, Goto Y, Nonaka I. Muscle coenzyme Q10 in mitochondrial encephalomyopathies. Neuromuscul Disord 1991;1:443-447.
26. Zierz S, Jahns G, Jerusalem F. Coenzyme Q in serum and muscle of 5 patients with Kearns-Sayre syndrome and 12 patients with ophthalmoplegia plus. J Neurol 1989;236:97-101.
27. Dallner G, Sindelaar PJ. Regulation of ubiquinone metabolism. Free Radic Biol Med 2000;29:285-294.
28. Grünler J, Ericsson J, Dallner G. Branch-point reactions in the biosynthesis of cholesterol, dolichol, ubiquinone and prenylated proteins. Biochim Biophys Acta 1994;1212:259-277.